featured
Biomarker Analyses of Patients With Metastatic TNBC Treated With Sacituzumab Govitecan vs Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Biomarker Analyses in the Phase III ASCENT Study of Sacituzumab Govitecan Versus Chemotherapy in Patients With Metastatic Triple-Negative Breast Cancer
Ann. Oncol 2021 Sep 01;32(9)1148-1156, A Bardia, SM Tolaney, K Punie, D Loirat, M Oliveira, K Kalinsky, A Zelnak, P Aftimos, F Dalenc, S Sardesai, E Hamilton, P Sharma, S Recalde, EC Gil, T Traina, J O'Shaughnessy, J Cortes, M Tsai, L Vahdat, V Diéras, LA Carey, HS Rugo, DM Goldenberg, Q Hong, M Olivo, LM Itri, SA HurvitzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.